The apical sodium-dependent bile acid transporter (ASBT, encoded by SLC10A2) is the sole transporter responsible for bile acid absorption in the human intestinal tract and is a therapeutic target for dyslipidemia. The gene discussed is SLC10A2; the disease is metabolic syndrome.